| abstract |
The present invention relates to IL-25 antibody VH domains and target binding members (eg, antibodies) that comprise said antibody VH domains and bind to IL-25. The invention also relates to compositions comprising target binding members (eg, antibodies) that bind to IL-25, methods for producing said target binding members and uses of said target binding members for the treatment or prevention of diseases. and conditions (for example, asthma and inflammatory bowel disease). |